CPT code 87149 identifies a molecular laboratory procedure that uses direct DNA or RNA probe techniques to further characterize an already isolated and identified organism, often to a more specific taxonomic level. This procedural code matters nationally because it supports precise microbial identification that can guide public health surveillance, infection control, and targeted antimicrobial strategies. Payers commonly involved in coverage and reimbursement discussions for this service include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.

Readers will find a concise overview of clinical context and the role of molecular probe testing in organism typing, along with national benchmarking and payer coverage considerations. The publication outlines typical sites of service and service type, summarizes common modifier usage where available, and highlights how this code interacts with laboratory workflows. It also covers policy updates and payer expectations relevant to molecular diagnostic billing, reimbursement patterns, and documentation practices. Data not available in the input are noted explicitly where applicable (for example, associated taxonomies, specific ICD-10 diagnoses, and related codes).